Agilon Health (NYSE:AGL) Receives Neutral Rating from BTIG Research

by · The Cerbat Gem

BTIG Research restated their neutral rating on shares of Agilon Health (NYSE:AGL – Free Report) in a research note published on Friday,Benzinga reports.

Several other equities research analysts also recently issued reports on the company. Weiss Ratings restated a “sell (e+)” rating on shares of Agilon Health in a research report on Wednesday, October 8th. Zacks Research raised Agilon Health from a “strong sell” rating to a “hold” rating in a report on Tuesday, October 21st. Sanford C. Bernstein reaffirmed a “market perform” rating and set a $1.40 target price (down previously from $4.00) on shares of Agilon Health in a report on Wednesday, August 20th. Barclays lowered their price target on shares of Agilon Health from $1.50 to $1.00 and set an “underweight” rating on the stock in a report on Thursday, November 6th. Finally, Wells Fargo & Company reduced their price objective on shares of Agilon Health from $1.50 to $1.00 and set an “overweight” rating for the company in a research note on Wednesday, November 5th. Four equities research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Agilon Health presently has a consensus rating of “Hold” and a consensus price target of $2.73.

Read Our Latest Analysis on AGL

Agilon Health Stock Down 0.2%

NYSE AGL opened at $0.72 on Friday. The company has a market cap of $298.08 million, a PE ratio of -0.96 and a beta of 0.07. Agilon Health has a 52 week low of $0.51 and a 52 week high of $6.08. The firm’s 50-day simple moving average is $0.77 and its two-hundred day simple moving average is $1.36.

Agilon Health (NYSE:AGL – Get Free Report) last posted its quarterly earnings results on Tuesday, November 4th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by ($0.09). The business had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.43 billion. Agilon Health had a negative net margin of 5.24% and a negative return on equity of 75.92%. As a group, equities research analysts anticipate that Agilon Health will post -0.59 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of AGL. CIBC Bancorp USA Inc. bought a new stake in Agilon Health during the third quarter valued at approximately $34,000. Jacobs Levy Equity Management Inc. lifted its holdings in shares of Agilon Health by 68.8% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 3,099,850 shares of the company’s stock worth $3,193,000 after acquiring an additional 1,263,677 shares during the last quarter. XTX Topco Ltd grew its position in Agilon Health by 26.3% in the third quarter. XTX Topco Ltd now owns 506,171 shares of the company’s stock worth $521,000 after acquiring an additional 105,411 shares in the last quarter. Voleon Capital Management LP increased its stake in Agilon Health by 5,519.2% in the third quarter. Voleon Capital Management LP now owns 2,741,039 shares of the company’s stock valued at $2,823,000 after acquiring an additional 2,692,259 shares during the last quarter. Finally, Numerai GP LLC bought a new position in Agilon Health in the third quarter valued at $412,000.

About Agilon Health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Articles